Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
INO80 complex subunit C is a proposed core structural and functional component of the INO80 chromatin remodeling complex, which is required for transcription, DNA replication, and DNA repair[3][4]. This multisubunit complex modulates chromatin structure and plays a critical role in genome stability, proper chromosome segregation, and the prevention of polyploidy[2]. INO80C, also known as IES6 or C18orf37, interacts with other subunits to form a large nucleoprotein complex. Loss or mutation of INO80C disrupts chromatin structure near centromeres, causes missegregation of chromosomes, and leads to genome instability—a feature relevant for cancer biology[2]. No drugs directly target INO80C, nor is it currently used as a clinical biomarker, but its function is fundamental to cellular genomic maintenance[2][3][7].
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on INO80 complex subunit C (INO80C).